Cubic Pharmaceuticals (003020.SZ): Marketing application for dimercaptopropane sulfonate sodium API accepted

date
16/11/2026
Zhitong Finance APP News, Lifang Pharmaceutical (003020.SZ) issued an announcement. Recently, the company received the "Notice of Acceptance" for the marketing application of Sodium Dimercaptopropanesulfonate API issued by the National Medical Products Administration. Sodium Dimercaptopropanesulfonate is a sulfhydryl-containing complex that has good detoxifying efficacy against poisoning by heavy metals such as lead, mercury, and arsenic, and is currently widely used in the clinical rescue of heavy metal poisoning.